IL13 and breast carcinoma: Similarly, the IL-33/ILC2 axis also accelerates tumor growth and promotes lung and liver metastasis by recruiting MDSCs to produce IL-13 in a mouse model of breast cancer (136), acute promyelocytic leukemia (APL), and prostate cancer (123).